Bioactivity | Feglymycin is a HIV replication inhibitor. Feglymycin is also an antibiotic peptide that has antibacterial activity (MIC: 32-64 μg/mL for Staphylococcus aureus)[1]. |
Name | Feglymycin |
CAS | 209335-49-9 |
Sequence | {d-nTyr}-{d-Phg(3,5-OH)}-Val-{d-Phg(3,5-OH)}-{nTyr}-{d-Phg(3,5-OH)}-{nTyr}-{d-Phg(3,5-OH)}-Val-{d-Phg(3,5-OH)}-{nTyr}-Phe-Asp |
Shortening | {d-nTyr}-{d-Phg(3,5-OH)}-V-{d-Phg(3,5-OH)}-{nTyr}-{d-Phg(3,5-OH)}-{nTyr}-{d-Phg(3,5-OH)}-V-{d-Phg(3,5-OH)}-{nTyr}-FD |
Formula | C95H97N13O30 |
Molar Mass | 1900.86 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Vértesy L, et al. Feglymycin, a novel inhibitor of the replication of the human immunodeficiency virus. Fermentation, isolation and structure elucidation. J Antibiot (Tokyo). 1999 Apr;52(4):374-82. [2]. Dettner F, et al. Total synthesis of the antiviral peptide antibiotic feglymycin. Angew Chem Int Ed Engl. 2009;48(10):1856-61. |